Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. IL-10 Rat anti-Human and Viral, Unlabeled, Clone: JES3-9D7, BD

IL-10 Rat anti-Human and Viral, Unlabeled, Clone: JES3-9D7, BD

Catalog No. BDB554497 Shop All BD Biosciences Products
Change view
Click to view available options
Quantity:
0.5 mg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
BDB554497 0.5 mg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. BDB554497 Supplier BD Biosciences Supplier No. 554497
Only null left
Add to Cart
Add to Cart

Description

Rat Monoclonal Antibody

The JES3-9D7 antibody reacts with human IL-10 and viral IL-10. The immunogen used to generate the JES3-9D7 hybridoma was recombinant human IL-10 expressed in COS cells.

TRUSTED_SUSTAINABILITY

Specifications

Antigen IL-10
Applications ELISA
Classification Monoclonal
Clone JES3-9D7
Concentration 0.5mg/mL
Conjugate Unconjugated
Description CSIF; Cytokine synthesis inhibitory factor; TGIF
Formulation Aqueous buffered solution containing ≤0.09% sodium azide.
Host Species Rat
Immunogen COS-expressed Recombinant Human IL-10
Purification Method Affinity Purified
Quantity 0.5 mg
Regulatory Status RUO
Research Discipline Immunology
Primary or Secondary Primary
Target Species Human, Virus
Content And Storage Store undiluted at 4°C
Isotype IgG1
Show More Show Less

For Research Use Only.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.